INS and Hyperglycemia: The majority of guidelines recommend insulin for the treatment of hyperglycaemia in GDM [16,19]; however, there are several barriers towards insulin use in this population, namely an undesirable route of administration, the potential for weight gain (which may further compound and propagate hyperglycaemia) and the risk of hypoglycaemia [20].